Grove Biopharma has signed a 17,000-square-foot lease for science-ready lab area in Chicago’s Fulton Market neighborhood. The 423,460-square-foot property, positioned at 400 N. Aberdeen St., is a part of Trammell Crow Co.’s Fulton Labs. CBRE’s Dan Lyne represented the proprietor, whereas Jonathan Metzl and Chip Evans of Cushman & Wakefield represented the tenant.
The biotech startup beforehand operated out of Portal Innovation’s Fulton Labs location. Because it relocates to a bigger area that can home its headquarters and laboratory, the agency will proceed its analysis on creating medicines to fight numerous ailments like most cancers.
TCC broke floor on the Aberdeen mission in 2020 and accomplished it two years later. The 16-story constructing has floorplates starting from 15,935 to 33,914 sq. toes, in addition to 12,000 sq. toes of retail area, in accordance with CommercialEdge knowledge. Grove Biopharma will likely be becoming a member of different tenants similar to Portal Improvements, Mattiq, Illinois Tech, Rhaeos and extra.
READ ALSO: Life Science Market Finds Its Spark
The mid-rise is roughly 16 miles from O’Hare Worldwide Airport and a couple of.7 miles from the Navy Pier. Downtown Chicago is 2.6 miles away, with numerous retail and eating choices close by.
The placement can be 9 miles from one other TCC life science growth, dubbed Hyde Park Labs. The developer began vertical building on the mission in 2023 and topped it out final yr.
TCC’s different ventures
As of this March, TCC had $12.8 billion in its growth pipeline. The corporate lately began building on a 1 million-square-foot industrial mission in Hagerstown, Md. When full, the build-to-suit facility will function the brand new major East Coast distribution middle for Lifetime Manufacturers.
One other ongoing growth is a House Depot facility in Stockton, Calif. TCC partnered with Realty Revenue Corp. for this $100 million mission that’s slated for supply in 2026.
